These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 309708)

  • 41. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors in chronic obstructive pulmonary disease (COPD).
    Cohen BH; Ball WC; Brashears S; Diamond EL; Kreiss P; Levy DA; Menkes HA; Permutt S; Tockman MS
    Am J Epidemiol; 1977 Mar; 105(3):223-32. PubMed ID: 300564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural history and clinical management of emphysema in patients with and without alpha 1-antitrypsin inhibitor deficiency.
    Turino GM
    Ann N Y Acad Sci; 1991; 624():18-29. PubMed ID: 2064220
    [No Abstract]   [Full Text] [Related]  

  • 44. Protease inhibitors in chronic obstructive pulmonary disease.
    Barnett TB; Gottovi D; Johnson AM
    Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency].
    Kishi F; Kakinoki A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):565-70. PubMed ID: 2615095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Survival of patients with severe alpha 1-antitrypsin deficiency].
    Seersholm NJ; Kok-Jensen A; Dirksen A
    Ugeskr Laeger; 1995 Apr; 157(17):2432-5. PubMed ID: 7762099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients.
    Yang P; Wentzlaff KA; Katzmann JA; Marks RS; Allen MS; Lesnick TG; Lindor NM; Myers JL; Wiegert E; Midthun DE; Thibodeau SN; Krowka MJ
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):461-5. PubMed ID: 10350443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural history of alpha-1-protease inhibitor deficiency.
    Hutchison DC
    Am J Med; 1988 Jun; 84(6A):3-12. PubMed ID: 3289386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of alpha 1-protease inhibitor deficiency.
    Hutchison DC
    Eur Respir J Suppl; 1990 Mar; 9():29s-34s. PubMed ID: 2340048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver function in asymptomatic adult individuals with severe alpha1-antitrypsin deficiency (Pi Z).
    Larsson C; Eriksson S
    Scand J Gastroenterol; 1977; 12(5):543-6. PubMed ID: 303370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The natural history of pulmonary emphysema and chronic bronchitis].
    Kurihara N; Fujimoto S; Hirata K
    Kokyu To Junkan; 1988 Sep; 36(9):935-40. PubMed ID: 3238182
    [No Abstract]   [Full Text] [Related]  

  • 54. alpha 1-Antitrypsin deficiency.
    Catz EG; Speir WA
    South Med J; 1984 Apr; 77(4):479-83. PubMed ID: 6324384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease.
    Chappell S; Hadzic N; Stockley R; Guetta-Baranes T; Morgan K; Kalsheker N
    Hepatology; 2008 Jan; 47(1):127-32. PubMed ID: 17972336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for alpha1-Pi deficiency in patients with lung diseases.
    Wencker M; Marx A; Konietzko N; Schaefer B; Campbell EJ
    Eur Respir J; 2002 Aug; 20(2):319-24. PubMed ID: 12212962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin.
    Reid CL; Wiener GJ; Cox DW; Richter JE; Geisinger KR
    Gastroenterology; 1987 Jul; 93(1):181-7. PubMed ID: 3034714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Alpha1-Antitrypsin deficiency: review of 6 cases. Pulmonary and skin alterations in a subject with complete alpha1-AT lack of the Pi OO type. Liver cirrhosis in an adult subject with major alpha1-AT deficiency (author's transl)].
    Schandevyl W; Hennebert A; Sergysels R; Stoffels G; Lemy-Debois N; Leblanc G; Achten G; De Roy G
    Acta Tuberc Pneumol Belg; 1974; 65(5):438-63. PubMed ID: 4549540
    [No Abstract]   [Full Text] [Related]  

  • 59. [Severe alpha 1-antitrypsin deficiency: clinical observations of 21 patients].
    Dürst A; Grob PJ
    Schweiz Med Wochenschr; 1978 Dec; 108(51):2040-6. PubMed ID: 310577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.
    Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG
    J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.